restor3d announced a strategic investment partnership with Partners Group. Under the agreement, Partners Group will acquire a significant minority stake in restor3d and provide $65 million of new equity. An additional $39 million was raised from existing shareholders as part of the transaction.
Proceeds from the investment will help restor3d advance product innovation and expand commercial growth. restor3d combines proprietary AI-driven design software, vertically integrated additive manufacturing and surgical planning to provide implants tailored to surgeon preference and patient anatomy across the shoulder, hip, knee, foot and ankle segments. In 2024 alone, the company partnered with more than 520 surgeons across 740 hospitals nationwide.
“restor3d is solving a key issue in the orthopedic market, namely that procedures have often relied on off-the-shelf products that cannot accommodate different patient anatomies. restor3d addresses this challenge by delivering rapid, precise patient-specific implants that lead to better surgical fit and function, ultimately improving patient outcomes,” said Ashley Torres, Member of Management, Private Equity, Partners Group.
restor3d announced a strategic investment partnership with Partners Group. Under the agreement, Partners Group will acquire a significant minority stake in restor3d and provide $65 million of new equity. An additional $39 million was raised from existing shareholders as part of the transaction.
Proceeds from the investment will help restor3d...
restor3d announced a strategic investment partnership with Partners Group. Under the agreement, Partners Group will acquire a significant minority stake in restor3d and provide $65 million of new equity. An additional $39 million was raised from existing shareholders as part of the transaction.
Proceeds from the investment will help restor3d advance product innovation and expand commercial growth. restor3d combines proprietary AI-driven design software, vertically integrated additive manufacturing and surgical planning to provide implants tailored to surgeon preference and patient anatomy across the shoulder, hip, knee, foot and ankle segments. In 2024 alone, the company partnered with more than 520 surgeons across 740 hospitals nationwide.
“restor3d is solving a key issue in the orthopedic market, namely that procedures have often relied on off-the-shelf products that cannot accommodate different patient anatomies. restor3d addresses this challenge by delivering rapid, precise patient-specific implants that lead to better surgical fit and function, ultimately improving patient outcomes,” said Ashley Torres, Member of Management, Private Equity, Partners Group.
Carolyn LaWell is ORTHOWORLD's Chief Content Officer. She joined ORTHOWORLD in 2012 to oversee its editorial and industry education. She previously served in editor roles at B2B magazines and newspapers.
Copy to clipboard 
